%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
AstraZeneca PLC(AZN) Stock Analysis | Healthcare
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.What is AstraZeneca PLC?
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
The brief on AstraZeneca PLC
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
What is AstraZeneca PLC?
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 184.09B, and a P/E ratio of 23.6x.
Financial Highlights
Investment Breakdown
Analysis
Reward: Moderate (65)Similar stocks to compare
A short list of Healthcare names that are close enough in size to make side-by-side comparison useful.
Openbook research
Articles mentioning AZN
- Read
Is Summit Therapeutics a Good Long-Term Investment? SMMT Growth, Profitability and Risks
AstraZeneca's USD 2bn stake removes Summit's financing overhang but buys no licence on ivonescimab. Why the shares gave back most of a 22% pop.
- Read
How to Export Hargreaves Lansdown Data to CSV and Excel
A step-by-step guide to downloading your Hargreaves Lansdown transaction history as a CSV or Excel file, what the export contains, the two quirks that catch people out, and what to do with the file once you have it.
- Read
GlaxoSmithKline PLC (GSK) Stock Analysis 2026: Vaccines Pipeline, Dividend Cover and Balance Sheet Fundamentals
This GSK stock analysis examines GlaxoSmithKline's Q2 2026 results, vaccines pipeline momentum, dividend cover and balance sheet position following the Nuvalent acquisition. Explore the key financial metrics and risks shaping the investment case in 2026.
- Read
Stock Analysis Platforms Compared: OpenBook vs Rivals
Not all stock analysis platforms are built the same. This guide compares the best stock analysis platforms — Morningstar, Seeking Alpha, Koyfin, Simply Wall St, and OpenBook Analytics — across depth, usability, and analytical framework to help you find the right fit for your investing style.